Form 4: 908 Devices Director Michele Leonhart Receives Significant Equity Awards

908 Devices Inc. Director Michele M. Leonhart was granted 14,083 Restricted Stock Units and options to purchase 6,516 shares of common stock on June 12, 2025, aligning her interests with long-term shareholder value.

Summary

• Michele M. Leonhart, a Director of 908 Devices Inc. (MASS), was granted equity awards on June 12, 2025.
• The awards include 14,083 Restricted Stock Units (RSUs) and options to purchase 6,516 shares of common stock.
• Each RSU represents a contingent right to receive one share of common stock, with a stated price of $0.00.
• The RSUs will fully vest on June 12, 2026, or the day prior to the 2026 Annual Meeting of Stockholders, whichever occurs first, contingent on continued service.
• A prorated number of RSUs will vest if service terminates for any reason.
• The stock options have an exercise price of $7.19 per share, with a stated price of $0.00 for the grant itself.
• The shares underlying the options will vest and become exercisable in substantially equal monthly installments over 12 months following June 12, 2025, subject to continued service.
• The stock options expire on June 11, 2035.

Sentiment

Score: 6

Explanation: The grant of equity awards to a director is generally a positive sign of alignment between management and shareholder interests, though it introduces minor potential for dilution.

Positives

• The grant of equity awards to Director Michele M. Leonhart aligns her interests with those of the shareholders, promoting long-term commitment and performance within 908 Devices Inc.

Negatives

• The issuance of new equity awards, while a standard compensation practice, can lead to minor dilution for existing shareholders over time as the awards vest and are exercised.

Risks

• Potential dilution of existing shareholder value upon the vesting and exercise of the granted Restricted Stock Units and stock options.
• The vesting of both RSUs and stock options is contingent on the reporting person's continued service, meaning the full benefit is not guaranteed if service terminates.

Future Outlook

The future outlook involves the vesting of 14,083 Restricted Stock Units by June 12, 2026, or the day prior to the 2026 Annual Meeting, and the vesting of 6,516 stock options over 12 months starting June 12, 2025, both contingent on the director's continued service.

Industry Context

This Form 4 filing reflects a routine equity compensation practice for directors, common across various industries to incentivize long-term commitment and align interests with shareholders, particularly in the technology and life sciences sectors where 908 Devices Inc. operates.

Related Party Transactions

• The document details the grant of 14,083 Restricted Stock Units and 6,516 stock options to Michele M. Leonhart, a Director of 908 Devices Inc., which constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• **Shareholders:** Potential for minor dilution from the vesting and exercise of equity awards, but also improved alignment of director interests with long-term shareholder value.
• **Employees:** No direct impact on general employees mentioned.
• **Customers/Suppliers/Creditors:** No direct impact mentioned.

Next Steps

• Continued service of Michele M. Leonhart to facilitate the vesting of her Restricted Stock Units and stock options.
• Vesting of 14,083 Restricted Stock Units by June 12, 2026, or prior to the 2026 Annual Meeting.
• Monthly vesting of 6,516 stock options over 12 months following June 12, 2025.

Key Dates

Keywords

908 Devices Inc., MASS, SEC Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSUs, Stock Options, Equity Awards, Corporate Governance, Beneficial Ownership